Profund Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Profund Advisors’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-38,551	Closed	-$257K	–	1163
2023 Q3	$257K	Buy	38,551 +1,996	+5%	+$16.6K	0.01%	741
2023 Q2	$331K	Buy	36,555 +3,846	+12%	+$33.9K	0.02%	669
2023 Q1	$238K	Buy	+32,709	New	+$243K	0.01%	875

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Profund Advisors's PNT Position: Q4 2023 in Review

Profund Advisors sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 38,551 shares — an estimated $257K sold.

Profund Advisors first reported a position in PNT in Q1 2023 and held it in 3 quarters. The position peaked at $331K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Profund Advisors reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Profund Advisors sold 38,551 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $257K.
Profund Advisors first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Profund Advisors's POINT Biopharma Global Inc. Common Stock position peaked at $331K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Profund Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.